Mycobacterium Citations List: January 2025

Literature Citations

1. Generating a Peptide Library Using the Repeats of Amino Acid Scaffolds Created by Sliding the Framework of a 7-mer Human Chemerin Segment and Discovery of Potent Antibacterial and Antimycobacterial Peptides. Akhtar, S., M.M. Ansari, R.D. Verma, J. Sharma, A. Gupta, R.K. Dhuriya, D.P. Verma, J. Saroj, M. Ali, N.K. Verma, K. Mitra, B.N. Singh, and J.K. Ghosh. Journal of Medicinal Chemistry, 2025. 68(1): p. 566-589. PMID[39718360].
[PubMed]. TB_01_2025.

2. Exploring the Antimycobacterial Potential of Podocarpusflavone a from Kielmeyera membranacea: In Vitro and In Vivo Insights. Araujo, M.H., S. Muñoz Sánchez, T. Simão, N. Nowik, S.S. Antunes, S.C. Pinto, D. Sorze, F. Boldrin, R. Manganelli, N. Correia Romeiro, E.B. Lasunskaia, F.J. Verbeek, H.P. Spaink, and M.F. Muzitano. Pharmaceuticals, 2024. 17(12). PMID[39770402]. PMCID[PMC11676425].
[PubMed]. TB_01_2025.

3. Synthesis, Biological Screening, and Molecular Docking of Hybrid Pyrazole Scaffolds for Antitubercular and Antimicrobial Activity. Bavishi, A., H. Vala, A. Radadiya, S. Swami, S. Thakrar, D. Sarkar, and A. Shah. Chemistryselect, 2025. 10(2): e202404830. ISI[001399968600001].
[WOS]. TB_01_2025.

4. Regio Selective Synthesis of Pyrazole Derivatives of 5-chloro-2-methoxy Phenyl Hydrazide and Their Biological Evaluation. Bavishi, A., H. Vala, S. Swami, S. Thakrar, A. Shah, and D. Sarkar. Journal of Heterocyclic Chemistry, 2025. ISI[001389868700001].
[WOS]. TB_01_2025.

5. Microwave-synthesized NiZrO(3)@Gnp and NiZrO(3)@MWCNT Nanocomposites: Enhanced Antimicrobial Efficacy against Biofilms and Mycobacterium smegmatis. Benitto, J.J., J.J. Vijaya, T.G. Saravanan, R. Manikkam, and B.H. Budhi. 3 Biotech, 2025. 15(2): p. 35. PMID[39790447]. PMCID[PMC11707131].
[PubMed]. TB_01_2025.

6. Antitubercular Activity of Silver(I) Complexes with 7-chloro-4-aminoquinolines: Synthesis, Characterization and In Vitro Biological Assays. D'Oliveira, K.A., I.O. Souza, N. Glanzmann, A.D. Da Silva, C.E.T. Bruziguini, M.A. Ribeiro, C.S.C. Canales, C.A. Roque-Borda, F.R. Pavan, and A. Cuin. Journal of Coordination Chemistry, 2024. ISI[001392779300001].
[WOS]. TB_01_2025.

7. Development and Evaluation of Amikacin-loaded Carbopol Hydrogel for Topical Treatment of Mycobacterium marinum Skin Infections. Francis, P.M., V. Vinod, V.A. Kumar, C.G. Mohan, and R. Biswas. Letters in Applied Microbiology, 2025. 78(1). PMID[39719398].
[PubMed]. TB_01_2025.

8. Arenicolide Family Macrolides Provide a New Therapeutic Lead Combating Multidrug-resistant Tuberculosis. Hwang, S., B.E. Heo, T.Q. Nguyen, Y.J. Kim, S.G. Lee, T.H. Huynh, E. Kim, S.I. Jo, M.J. Baek, E.K. Shin, J. Oh, C. Park, Y.J. Yoon, E.J. Park, K.T. Kim, S. Ryoo, D.G. Lee, C. Wood, M. Woo, D.D. Kim, S. Paik, E.K. Jo, J. Jang, and D.C. Oh. Angewandte Chemie International Edition, 2025. 64(1): e202412994. PMID[39400949]. PMCID[PMC11701349].
[PubMed]. TB_01_2025.

9. Synthesis, Characterization and Biological Profile of Some New Dihydropyrimidinone Derivaties. Kanwal, M., H. Nadeem, S. Malik, and S. Maqsood. Heliyon, 2025. 11(1): e41152. PMID[39811294]. PMCID[PMC11730207].
[PubMed]. TB_01_2025.

10. Exploration of Vanoxerine Analogues as Antibacterial Agents. Kingdon, A.D.H., H.V. Adcock, E.M. Kasimati, P. Craven, W. van Schaik, L.R. Cox, and G.S. Besra. Journal of Antibiotics, 2025. 78(1): p. 54-63. PMID[39402358]. PMCID[PMC11700842].
[PubMed]. TB_01_2025.

11. Expanding the Chemical Space of Reverse Fosmidomycin Analogs. Knak, T., S. Takada, B. Illarionov, V. Krisilia, L. Pessanha de Carvalho, B. Lungerich, Y. Sakamoto, S. Höfmann, A. Bacher, R. Kalscheuer, J. Held, M. Fischer, N. Tanaka, and T. Kurz. ACS Medicinal Chemistry Letters, 2025. 16(1): p. 136-143. PMID[39811140]. PMCID[PMC11726376].
[PubMed]. TB_01_2025.

12. Trifluoromethylcinnamanilides - Effective Dual Inhibitors of Mycobacterium smegmatis and Plasmodium falciparum. Kos, J., T. Strharsky, R. Tosso, L. Gutierrez, D. Kos, J. Jurica, O. Zendulka, O. Pes, J. Gregorova, G. Degotte, T. Gonec, M. Oravec, V. Vojackova, V. Krystof, A. Cizek, P. Francotte, M. Frederich, J. Jampilek, and D. Enriz. Bioorganic Chemistry, 2025. 154: 107957. PMID[39615279].
[PubMed]. TB_01_2025.

13. «Green-Ligand» in Metallodrugs Design-Cu(II) Complex with Phytic Acid: Synthetic Approach, EPR-spectroscopy, and Antimycobacterial Activity. Koshenskova, K.A., N.V. Makarenko, F.M. Dolgushin, D.S. Yambulatov, O.B. Bekker, M.V. Fedin, S.A. Dementev, O.A. Krumkacheva, I.L. Eremenko, and I.A. Lutsenko. Molecules, 2025. 30(2). PMID[39860183]. PMCID[PMC11767443].
[PubMed]. TB_01_2025.

14. Development of Tetracycline Analogues with Increased Aqueous Stability for the Treatment of Mycobacterial Infections. Liu, J., G.A. Phelps, C.M. Dunn, P.A. Murphy, L.A. Wilt, V. Loudon, R.B. Lee, D. Fernando, L. Yang, K.N. Tran, B.T. Troyer, A. Obregon-Henao, and R.E. Lee. Tuberculosis, 2025. 150: 102592. PMID[39708619].
[PubMed]. TB_01_2025.

15. Identification of BMVC-8C3O as a Novel Pks13 Inhibitor with Anti-tuberculosis Activity. Liu, T., J. Meng, B. Wang, X. Li, Q. Wang, S. Liu, Y. Guan, X. Wang, and Y. Liu. Tuberculosis, 2025. 150: 102579. PMID[39579511].
[PubMed]. TB_01_2025.

16. Novel 3-aminothieno[2,3-B]pyridine-2-carboxamides with Activity against Mycobacterium tuberculosis. Lynde, B.E., D.M. Chemaly, V.P. Baldin, E. Greve, C.L. Harding, J.M. Graner, M. Hardy, S. Chowdhury, and T. Parish. ACS Medicinal Chemistry Letters, 2025. ISI[001389937300001].
[WOS]. TB_01_2025.

17. Biflavonoids and Bi- and Tricoumarins from Daphne Mezereum and Inhibition of TNF-a Secretion. Mohamed, W.N., H.S. Butt, T.J. Schmidt, A.A. Eltvik, D. Wu, K.E. Malterud, M. Inngjerdingen, K.T. Inngjerdingen, and H. Wangensteen. Phytochemistry, 2025. 229: 114308. PMID[39433079].
[PubMed]. TB_01_2025.

18. Targeting InhA in Drug-resistant Mycobacterium tuberculosis: Potent Antimycobacterial Activity of Diaryl Ether Dehydrozingerone Derivatives. Mubarak, M.M., H.A. Kantroo, F.A. Mir, C. Kumar, and Z. Ahmad. Archives of Microbiology, 2025. 207(2): p. 34. PMID[39812792].
[PubMed]. TB_01_2025.

19. Biomolecular Interaction of Carnosine and Anti-Tb Drug: Preparation of Functional Biopeptide-Based Nanocomposites and Characterization through in Vitro and in Silico Investigations. Nagarajan, U., A. Naha, G. Ashok, A. Balasubramanian, S. Ramaiah, V.K. S, A. Dusthackeer, A. Anbarasu, and S. Natarajan. ACS Omega, 2025. 10(1): p. 567-587. PMID[39829512]. PMCID[PMC11739970].
[PubMed]. TB_01_2025.

20. Design, Synthesis, In Vitro and In Silico Studies of 1,2,3-triazole Incorporated Tetrazoles as Potent Antitubercular Agents. Narkedimilli, V.K.K., T.R. Allaka, R. Balli, S. Bhoomandla, S.R. Purumandla, and K. Venkateswarlu. Journal of Molecular Structure, 2025. 1327: 141242. ISI[001402903300001].
[WOS]. TB_01_2025.

21. Antimicrobial and Antiproliferative Properties of 2-phenyl-N-(pyridin-2-yl)acetamides. Nawrot, D., B. Koutníková, O. Janďourek, K. Konečná, M. Novák, P. Paterová, P. Bárta, G. Bouz, J. Zitko, and M. Doležal. Chemical Biology & Drug Design, 2025. 105(1): e70030. PMID[39835639]. PMCID[PMC11748363].
[PubMed]. TB_01_2025.

22. Discovery of Acetohydroxyacid Synthase Inhibitors as Anti-tuberculosis Lead Compounds from Natural Products. Niu, Y., Z. Wu, Q. Hu, Y. Wu, Q. Jiang, and X. Yang. Bioorganic & Medicinal Chemistry, 2025. 118: 118041. PMID[39708691].
[PubMed]. TB_01_2025.

23. Drug-loaded Liposomes for Macrophage Targeting in Mycobacterium tuberculosis: Development, Characterization and Macrophage Infection Study. Nongkhlaw, R., R. Nongrum, J. Arunachalam, N.P. Kalia, P.K. Agnivesh, and R. Nongkhlaw. 3 Biotech, 2025. 15(2): p. 52. PMID[39898235]. PMCID[PMC11782762].
[PubMed]. TB_01_2025.

24. 6-aryloxy-2-aminopyrimidine-benzonitrile Hybrids as Anti-infective Agents: Synthesis, Bioevaluation, and Molecular Docking. Pranathi, A.N., N. Devendra, R.K. Bollikanda, P.K. Bangalore, I.L. Esaulkova, M.G. Mikhalsky, M.A. Niukalova, V.V. Zarubaev, B. Sridhar, and S. Kantevari. Archiv der Pharmazie, 2025. 358(1): e2400580. PMID[39721989].
[PubMed]. TB_01_2025.

25. SQ31f Is a Potent Non-tuberculous Mycobacteria Antibiotic by Specifically Targeting the Mycobacterial F-ATP Synthase. Ragunathan, P., P. Sae-Lao, A. Harikishore, W. Daher, F. Roquet-Banères, L. Kremer, R.W. Bates, and G. Grüber. Journal of Antimicrobial Chemotherapy, 2025. 80(1): p. 270-280. PMID[39499211].
[PubMed]. TB_01_2025.

26. 4-alkyl-4H-thieno[2',3':4,5]pyrrolo[2,3-B]quinoxaline Derivatives as New Heterocyclic Analogues of Indolo[2,3-B]quinoxalines: Synthesis and Antitubercular Activity. Sadykhov, G.A., D.V. Belyaev, E.E. Khramtsova, D.V. Vakhrusheva, S.Y. Krasnoborova, D.V. Dianov, M.G. Pervova, G.L. Rusinov, E.V. Verbitskiy, and V.N. Charushin. International Journal of Molecular Sciences, 2025. 26(1). PMID[39796223]. PMCID[PMC11720412].
[PubMed]. TB_01_2025.

27. A New N-acylhydrazone Oxadiazole Derivative with Activity against Mycobacteria. Souza, I.V., M.L. Fróes da Motta Dacome, A.M. Frederico Rozada, J.S. Rosa, E.G. Sampiron, D.G. Ferreira, G.F. Gauze, M.F. Norman Negri, R.B. de Lima Scodro, R.F. Cardoso, and K.R. Caleffi-Ferracioli. Future Microbiology, 2025. 20(1): p. 33-44. PMID[39440547].
[PubMed]. TB_01_2025.

28. Synthesis, Molecular Dynamics Simulation and Antimicrobial Activity of Novel S-triazine Clubbed with Three Different Hybrid Pharmacophores. Tailor, R.P., K.G. Prajapati, M.A. Isa, and A.P. Kappo. Biochemical and Biophysical Research Communications, 2025. 749: 151358. PMID[39855044].
[PubMed]. TB_01_2025.

29. The New Thiazolidine-2,4-dione-based Hybrids with Promising Antimycobacterial Activity: Design, Synthesis, Biological Evaluation, and Drug Interaction Analysis. Trotsko, N., A. Głogowska, B. Kaproń, K. Kozieł, E. Augustynowicz-Kopeć, and A. Paneth. Journal of Enzyme Inhibition and Medicinal Chemistry, 2025. 40(1): 2442703. PMID[39749402]. PMCID[PMC11703137].
[PubMed]. TB_01_2025.

30. Structure-based Development of N-arylindole Derivatives as PKS13 Inhibitors against Mycobacterium Tuberculosis. Zhang, X., S.C. Lun, Y.X. Li, W. Zhang, R.Y. Zhou, T. Liu, F. Yang, J. Tang, W.R. Bishai, and L.F. Yu. European Journal of Medicinal Chemistry, 2025. 283: 117148. ISI[001393988200001].
[WOS]. TB_01_2025.

Patent Citations

31. Carbazole Compounds and Their Use in Therapy, in the Treatment of a Respiratory Infection. Hailes, H., L. Martin, S. Bhakta, and C. Daniel. Patent. 2025. WO2025-GB517902024012634: 97pp.
[Patent]. TB_01_2025.